Form 4: Broadridge Director Eileen Murray Receives Equity Grants

Broadridge Financial Solutions Director Eileen Murray was granted 831 Deferred Stock Units and 3,182 stock options, vesting immediately.

Summary

• Eileen K. Murray, a Director of Broadridge Financial Solutions, Inc. (BR), received equity grants.
• She acquired 831 shares of Common Stock in the form of Deferred Stock Units (DSUs) on November 13, 2025.
• These DSUs were granted under Broadridge's 2018 Omnibus Award Plan, vested immediately, and will settle in shares upon her separation from service.
• Following this transaction, she beneficially owns 4,543 shares of Common Stock.
• She also acquired 3,182 stock options on November 13, 2025, with an exercise price of $225.61.
• These stock options vested immediately upon grant and have an expiration date of November 13, 2035.
• Following this transaction, she beneficially owns 3,182 stock options.

Sentiment

Score: 7

Explanation: The filing reports a routine equity grant to a director, which is a positive for aligning interests but does not indicate significant operational or financial news. The immediate vesting is a standard practice for director compensation.

Positives

• Director Eileen Murray received equity compensation, aligning her interests with shareholders.
• The immediate vesting of both Deferred Stock Units and stock options indicates a direct and immediate benefit to the director.
• The grant of DSUs and stock options is a common practice for director compensation, reflecting standard corporate governance.

Future Outlook

This filing does not contain forward-looking statements or guidance.

Industry Context

This is a routine insider transaction filing (Form 4) reporting equity compensation for a director. Such grants are standard practice across industries to align director incentives with shareholder value, particularly in the financial technology sector where Broadridge operates.

Comparison to Industry Standards

• The grant of Deferred Stock Units and stock options to a director is a common form of equity compensation in publicly traded companies, including those in the financial services and technology sectors.
• The immediate vesting of these awards is also typical for director compensation, often tied to board service rather than performance metrics, unlike executive compensation.
• No specific comparable companies or projects are detailed in this transactional filing.

Corporate Governance

Stakeholder Impact

• Shareholders: The equity grants align the director's interests with shareholders, potentially fostering better long-term decision-making.
• Director (Eileen K. Murray): Receives equity compensation, increasing her stake and potential future wealth in the company.

Next Steps

• The Deferred Stock Units will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.
• The stock options can be exercised at any time until their expiration date of November 13, 2035.

Key Dates

Recommendation

This Form 4 filing details a routine equity compensation grant to a director, which is a standard practice for aligning management and director interests with shareholders. It does not provide new operational or financial information that would warrant a change in investment recommendation. The transaction itself is neutral to slightly positive as it reinforces alignment, but it's not a catalyst for a 'buy' or 'sell' decision.

Keywords

Broadridge Financial Solutions, BR, Eileen Murray, Form 4, Insider Transaction, Equity Grant, Deferred Stock Units, Stock Options, Director Compensation, Beneficial Ownership